SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-17-022635
Filing Date
2017-04-27
Accepted
2017-04-27 16:05:59
Documents
6
Period of Report
2017-04-27

Document Format Files

Seq Description Document Type Size
1 6-K v465223_6k.htm 6-K 19204
2 EXHIBIT 99.1 v465223_exh99x1.htm EX-99.1 283545
3 EXHIBIT 99.2 v465223_ex99-2.htm EX-99.2 35639
4 GRAPHIC line.gif GRAPHIC 43
5 GRAPHIC spacer.gif GRAPHIC 43
6 GRAPHIC ex99x2_p1.jpg GRAPHIC 1048
  Complete submission text file 0001144204-17-022635.txt   341357
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36345 | Film No.: 17789060
SIC: 2834 Pharmaceutical Preparations